Search for Clinical Trial Results

Sponsored By

Acute Erythroid Leukemia - 171 Studies Found

Status Study
Withdrawn Study Name: Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission
Condition:
  • Adult Acute Erythroid Leukemia
  • Adult Acute Monoblastic and Acut
    Date: 2005-01-07
    Interventions:
    • Drug: anti-thymocyte globulin
    • Drug: fludar
Completed Study Name: Molecular Characterization of Acute Erythroid Leukemia (M6-AML) Using Targeted Next-generation Sequencing
Condition: Acute Myeloid Leukemia
Date: 2016-07-08
Interventions: Other: DNA sequencing
Terminated Study Name: Study of Panobinostat Monotherapy in Women With v-ERB-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 (HER2) Positive Locally Recurrent or Metastatic Breast Cancer
Condition: Breast Cancer
Date: 2008-10-21
Interventions:
  • Drug: Panobinostat - LBH589 So
Completed Study Name: Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia
Condition:
  • Adult Acute Basophilic Leukemia
  • Adult Acute Eosinophilic Leukemia
  • Drug: cytarabine Given IV
Active, not recruiting Study Name: Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Condition:
  • Acute Erythroid Leukemia
  • Acute Megakaryoblastic Leukemia
    • <
    Date: 2006-10-25
    Interventions:
    • Drug: Azacitidine Given SC
Recruiting Study Name: Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes
Condition:
  • Acute Biphenotypic Leukemia
  • Acute Erythroid Leukemia
  • Date: 2012-09-19
    Interventions:
    • Drug: Cyclophosphamide Given I
Completed Study Name: Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies
Condition:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remissi
    Date: 2011-08-31
    Interventions:
    • Drug: cyclophosphamide Given I
Completed Study Name: Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia
Condition:
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • Adult Acute Monoblastic Leukemia (M5a)
  • Date: 2013-02-26
    Interventions:
    • Drug: mitoxantrone hydrochloride

Active, not recruiting Study Name: Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Condition:
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • Adult Acute Minimally Differentiated Myeloid Leuk
    Date: 2011-03-01
    Interventions:
    • Drug: caspofungin acetate Give
Completed Study Name: High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma
Condition:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remissi
    Date: 2010-08-05
    Interventions:
    • Drug: busulfan Given orally
Next >>>